8-K filed May 21, 2026, 6:51 AM ET ticker WGRX CIK 0002030763

M&A confidence medium sentiment neutral materiality 0.85

Wellgistics Health enters binding term sheet for DelivMeds AI; announces 1-for-50 reverse stock split

Wellgistics Health, Inc.

Binding term sheet with Datavault AI (DVLT), Scilex (SCLX) and others to form DelivMeds AI; combined asset value expected $4B (subject to fairness opinion).
Existing public stockholders projected to retain ~10.4% of common post-conversion; new parties to own ~89.6% via convertible preferred.
Wellgistics to acquire QOLPOM biometric IP from EOS/SCLX, expand PharmacyChain license to HaaS, and acquire controlling stake in Tollo Health (Health Lives Here).
1-for-50 reverse stock split effective May 26, 2026 to regain Nasdaq minimum bid compliance; shares reduce from ~125.7M to ~2.5M.
Note purchase agreement amended: principal increased to $1.5M with additional $200K funding; Gerald Commissiong appointed Interim Co-CEO.

item 1.01 item 2.03 item 3.02 item 3.03 item 5.03 item 5.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-024723
form_type: 8-K
ticker: WGRX
cik: 0002030763
company_name: Wellgistics Health, Inc.
filed_at: 2026-05-21T10:51:51+00:00
discovered_at: 2026-05-21T10:55:00.270501+00:00
generated_at: 2026-05-21T10:58:55.403206+00:00
sec_items: ["1.01", "2.03", "3.02", "3.03", "5.03", "5.02", "9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: medium
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-024723
json_url: https://secwatch.observer/filing/0001493152-26-024723.json
markdown_url: https://secwatch.observer/filing/0001493152-26-024723.md
text_url: https://secwatch.observer/filing/0001493152-26-024723.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2030763/000149315226024723/0001493152-26-024723-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2030763/000149315226024723/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Gerald Commissiong

Interim Co-Chief Executive Officer

WGRX · Wellgistics Health, Inc.

Effective: 2026-05-20
Filed: May 21, 2026, 6:51 AM ET

On May 20, 2026, in connection with the Term Sheet described in Item 1.01 of this Current Report on Form 8-K, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Gerald Commissiong as Interim Co-Chief Executive Officer of the Company, effective immediately.

Source-grounded claims

0595960505

Gerald Commissiong was appointed as Interim Co-Chief Executive Officer at Wellgistics Health, Inc..

On May 20, 2026, in connection with the Term Sheet described in Item 1.01 of this Current Report on Form 8-K, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Gerald Commissiong as Interim Co-Chief Executive Officer of the Company, effective immediately.

SEC 8-K Item 5.02 confidence 1.0 SEC evidence

f492c9abc600ba21be09bc0ff8e9d6be79f751a9

Wellgistics Health, Inc.: Certificate of Amendment to effect a 1-for-50 reverse stock split of common stock (effective 2025-05-26).

On May 20, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

Comparable filings

XRN

Chiron Real Estate closes $249M acquisition of two senior housing communities; issues $100M Series C preferred

Chiron Real Estate Inc. June 2, 2026, 4:30 PM ET m_and_a Items 1.01, 2.01, 2.03, 3.02, 3.03, 5.03, 9.01

same fact type: governance_change same SEC item: 1.01, 2.03, 3.02, 3.03, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On May 20, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

Comparable filing

On May 28, 2026, the Company filed Articles Supplementary with the Maryland State Department of Assessments and Taxation to designate 1,000,000 shares of the Company’s authorized preferred stock as shares of Series C Convertible Preferred Stock

Filing page SEC filing

OCFC

OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus

OCEANFIRST FINANCIAL CORP June 1, 2026, 5:19 PM ET m_and_a Items 1.01, 3.02, 2.01, 2.03, 3.03, 5.02, 5.03, 7.01, 9.01

same fact type: executive_change same SEC item: 1.01, 2.03, 3.02, 3.03, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On May 20, 2026, in connection with the Term Sheet described in Item 1.01 of this Current Report on Form 8-K, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Gerald Commissiong as Interim Co-Chief Executive Officer of the Company, effective immediately.

Comparable filing

Todd Schell, designated by Warburg, was appointed to serve as a director of OceanFirst

Filing page SEC filing

Enviri II Corp

New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA

Enviri II Corp June 1, 2026, 5:18 PM ET m_and_a Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01

same fact type: governance_change same SEC item: 1.01, 2.03, 3.03, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On May 20, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

Comparable filing

In connection with the Spin-Off, the Board adopted the Code of Conduct, a copy of which is available on New Enviri’s website at www.enviri.com.

Filing page SEC filing

GIG

Hadron Energy closes SPAC merger with GigCapital7; 84% of public shares redeemed

GigCapital7 Corp. May 29, 2026, 7:45 PM ET m_and_a Items 2.01, 3.02, 5.02, 9.01, 3.03, 4.01, 5.01, 5.03, 5.06, 8.01

same fact type: executive_change, governance_change same SEC item: 3.02, 3.03, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On May 20, 2026, in connection with the Term Sheet described in Item 1.01 of this Current Report on Form 8-K, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Gerald Commissiong as Interim Co-Chief Executive Officer of the Company, effective immediately.

Comparable filing

and each of the directors having been elected by the GigCapital7 stockholders to the board also upon the Closing on May 22, 2026

Filing page SEC filing

Matternet, Inc.

Matternet goes public via reverse merger with Los Altos Ventures, $27.6M PIPE

Matternet, Inc. May 29, 2026, 5:21 PM ET m_and_a Items 1.01, 2.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.06, 9.01

same fact type: governance_change same SEC item: 1.01, 3.02, 3.03, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On May 20, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

Comparable filing

At the Effective Time, we amended and restated our certificate of incorporation.

Filing page SEC filing

CECO

CECO Environmental completes acquisition of Thermon Group Holdings, issues ~22.5M shares and pays $329.4M cash

CECO ENVIRONMENTAL CORP June 1, 2026, 9:16 AM ET m_and_a Items 2.01, 2.03, 5.02, 5.03, 7.01, 9.01

same fact type: executive_change, governance_change same SEC item: 2.03, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On May 20, 2026, in connection with the Term Sheet described in Item 1.01 of this Current Report on Form 8-K, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Gerald Commissiong as Interim Co-Chief Executive Officer of the Company, effective immediately.

Comparable filing

the Board appointed Todd Gleason, CECO’s Chief Executive Officer and an existing member of the Board, to serve as Chairman of the Board, effective as of the effective time of the First Merger.

Filing page SEC filing

OLOX

Olenox acquires CS Digital for $30M upfront; launches gas-powered data center platform

OLENOX INDUSTRIES INC. May 28, 2026, 8:30 AM ET m_and_a Items 1.01, 5.03, 2.01, 2.03, 3.02, 7.01, 8.01, 9.01

same fact type: governance_change same SEC item: 1.01, 2.03, 3.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On May 20, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

Comparable filing

On May 26, 2026, in connection with the closing of the Acquisition, the Company filed a Certificate of Designation of Series D Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges and restrictions of the Series D Preferred Stock.

Filing page SEC filing

ESAB

ESAB completes $1.45B acquisition of Eddyfi Technologies

ESAB Corp June 2, 2026, 6:41 AM ET m_and_a Items 2.01, 3.02, 5.03, 3.03, 7.01, 8.01, 9.01

same fact type: governance_change same SEC item: 3.02, 3.03, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On May 20, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

Comparable filing

On June 1, 2026, the Company filed the Certificate of Designations with the Delaware Secretary of State to establish the preferences, limitations and relative rights of its 6.50% Series A Mandatory Convertible Preferred Stock (the “ Series A Mandatory Convertible Preferred Stock ”), which became effective upon filing.

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-26-024723

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.